Spermidine Autophagy: 187 Elderly Heart Patients, Answers This August
One hundred and eighty-seven people. All of them are 65 or older, all have coronary artery disease, and all of them are taking 24mg of spermidine every day for 48 weeks. That is the structure of POLYCAD, a randomized double-blind controlled trial running at Aarhus University Hospital in Denmark. Enrollment began in January 2024. The data closes in August 2026.
By the time that clock runs out, POLYCAD will be the largest clinical trial ever to directly ask whether spermidine changes autophagy markers and cardiovascular aging indicators in elderly heart patients. The question sitting at its center: does the molecule that declines as we age actually slow the biological processes that make aging hearts fail?
What Spermidine Is
Spermidine belongs to a class of compounds called polyamines. These are small molecules involved in cell growth, DNA stabilization, and protein synthesis. Spermidine is the most studied member of the group.
The body synthesizes spermidine on its own, but production drops with age. Studies comparing blood concentrations between younger and older adults consistently show declines in the range of several dozen percent by the seventh decade. Food also supplies polyamines, but that input shrinks too as diets shift with age. The result is a compounding deficit: less synthesis, less dietary intake, lower total polyamine availability.
The consequence that researchers care about most is reduced autophagy. When spermidine levels are adequate, cells efficiently clear out aging mitochondria and misfolded proteins through a self-digestion process. When polyamines fall, that clearing slows. Cellular debris accumulates. The cells themselves start to operate less efficiently.
The Autophagy-Cardiovascular Aging Connection
Cardiac muscle cells (cardiomyocytes) are almost irreplaceable. Unlike skin or gut cells, which turn over constantly, heart cells largely stay with you for life. A damaged cardiomyocyte does not get swapped out for a fresh one. It either repairs itself through mechanisms like autophagy, or it continues functioning at reduced capacity for decades.
This makes the heart uniquely dependent on autophagy for long-term function. Each cardiomyocyte contains thousands of mitochondria. The heart is one of the highest energy-consuming organs in the body, running on ATP produced continuously by this mitochondrial network. As mitochondria age or sustain oxidative damage, ATP output drops and reactive oxygen species production rises. Mitophagy, the selective autophagy pathway that targets dysfunctional mitochondria for removal, is how the heart keeps that network functional.
Spermidine activates this pathway through a well-characterized mechanism: it promotes hypoacetylation of histones (the proteins that DNA wraps around), which in turn increases expression of autophagy-related genes. This has been confirmed repeatedly in cell and animal models. What POLYCAD is testing is whether that mechanism translates into measurable cardiovascular outcomes in living humans over nearly a year.
There is also a plaque-stability angle for coronary artery disease specifically. Research suggests that impaired autophagy within atherosclerotic plaques correlates with plaque instability. Sufficient autophagy appears to help the cells that make up plaques maintain a more stable configuration.
What POLYCAD Is Testing, and What It Is Not
The trial name tells you the hypothesis directly: POLYamine Coronary Artery Disease.
The design is a single-center, double-blind, randomized, placebo-controlled trial. 187 participants aged 65 and older with established coronary artery disease are split into two groups: 24mg/day spermidine or placebo for 48 weeks. Primary endpoints include autophagy markers and cardiovascular aging biomarkers. Enrollment started January 4, 2024. Completion is expected August 2026.
The 24mg/day dose is a meaningful number. Wheat germ contains approximately 24–25mg of spermidine per 100g. The daily intervention dose is essentially what you would get from 100g of wheat germ, delivered in a concentrated supplement form.
There is a limitation worth naming. A prior trial using 40mg/day of spermidine for 8 weeks showed minimal changes in circulating polyamine levels. Oral spermidine’s bioavailability and its pathway from gut to cardiomyocyte are not fully mapped. POLYCAD’s 48-week timeframe is long enough to detect slower-moving changes, but the question of whether oral supplementation meaningfully shifts systemic polyamine pools remains part of what this trial is answering.
A separate US trial is also underway, testing a combination protocol of spermidine plus exercise plus anti-inflammatory agents. Where POLYCAD isolates the spermidine variable, the US trial is exploring whether synergies exist across multiple longevity mechanisms simultaneously.
Getting to 24mg Through Food
The POLYCAD dose is achievable through diet in theory. In practice, it requires deliberate planning.
Wheat germ is the highest-density food source at roughly 24–25mg per 100g. Cheonggukjang and natto (fermented soybeans) come in around 10–12mg per 100g. Sunflower seeds land at approximately 8–9mg per 100g. Aged cheeses range from 4–7mg per 100g depending on the variety. Legumes, mushrooms, and corn contribute 1–4mg per 100g.
A diet centered on vegetables, legumes, and whole grains can reasonably supply 10–15mg/day without specific effort. Reaching 24mg/day requires adding wheat germ deliberately or combining multiple high-spermidine foods consistently. The dietary patterns that appear in longevity research, including Mediterranean and traditional Okinawan diets, are notable for polyamine content among other factors.
Spermidine is categorized as a calorie restriction mimetic. The term means it activates cellular responses associated with caloric restriction, particularly autophagy upregulation, without requiring actual reduction in food intake. The pathway it uses overlaps with intermittent fasting-induced autophagy. This positions it within a broader field of research asking whether fasting’s cellular benefits can be replicated pharmacologically.
Supplement Forms and What to Look For
Most commercial spermidine supplements use wheat germ extract as the primary ingredient. Standard products contain 1–2mg of spermidine per capsule or tablet. Some higher-concentration products list 5mg or more per serving.
The most important label detail is whether the product specifies spermidine content in mg rather than just wheat germ extract weight. These are not the same number. 500mg of wheat germ extract does not equal 500mg of spermidine. Products that clearly state spermidine content allow for meaningful comparison.
For people with gluten sensitivity, the source material matters. Most wheat germ extracts are processed to remove gluten to varying degrees, but confirmation from the manufacturer is worth seeking. Some formulations use alternative plant sources that naturally contain spermidine.
Who Benefits and Who Should Be Cautious
The most relevant population for POLYCAD’s findings is adults with cardiovascular risk factors who are looking at cellular-level approaches alongside diet and exercise. People in their 40s and 50s with family history, hypertension, or metabolic irregularities have the most to gain from what August’s data will show.
There are populations for whom caution applies. Spermidine promotes cell growth. People currently undergoing cancer treatment or with a recent cancer history should discuss supplementation with their oncologist before proceeding. The relationship between autophagy and cancer cell survival is context-dependent and not straightforwardly beneficial in all scenarios.
Inflammatory bowel disease alters polyamine metabolism in ways that make the effects of supplementation less predictable. Pregnancy is a period when endogenous polyamine production is already elevated to support fetal development, and supplemental addition is not generally recommended.
August 2026 will sharpen the picture considerably. Until then, the case for spermidine is built on mechanism, animal data, small human trials, and coherent epidemiology from high-spermidine dietary patterns. POLYCAD is the trial that will either validate or qualify all of it with 187 patients and 48 weeks of direct measurement.
Q. Can you get enough spermidine from food alone?
Wheat germ contains roughly 24–25mg of spermidine per 100g, so in theory you can reach the POLYCAD dose through diet. In practice, eating that amount of wheat germ daily isn’t realistic for most people. Combining fermented soybeans (natto or cheonggukjang), sunflower seeds, aged cheese, and wheat germ across meals is a more achievable strategy. Wheat germ extract supplements that clearly state spermidine content (in mg per serving) are the other option.
Q. Is it safe to take spermidine before the POLYCAD results are published?
The current safety profile looks reasonable at dietary and low supplemental doses. What’s missing is the cardiovascular-specific data that POLYCAD will provide. There’s a meaningful difference between a healthy adult adding spermidine-rich foods to their diet and a coronary artery disease patient taking high-dose supplements before August’s results are in.
Q. What forms of spermidine supplements are available?
Most products use wheat germ extract as the base ingredient. Look for products that list spermidine content in mg per serving rather than just the raw extract weight, as those two numbers are not interchangeable. If you have gluten sensitivity, check whether the extract has been processed to remove gluten or look for non-wheat sources. Note that a previous trial using 40mg/day for 8 weeks showed minimal changes in circulating polyamine levels, suggesting that oral bioavailability and dosing optimization are still active research questions.